index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Ex-vivo Hepatocellular carcinoma Animal/physiopathology Muscles/physiopathology DMO Dystrophy Muscular Dystrophy Myotendinous junction MES Centronuclear myopathy LKB1 Human Umbilical Vein Endothelial Cells Genomic L-Type Base Sequence Duchenne muscular dystrophy Autophagy Long QT Cells Metabolism Modificateurs de gènes Dystrophie Musculaire de Duchenne DMD Cachexia Gene Expression Regulation/drug effects Inhibitors BMD CD38 Cell Biology Dystrophin Drp1 Antisense oligonucleotides Morphogenesis NNOS Exon skipping Delivery Muscle Cell homeostasis Muscular dystrophy Muscular Atrophy Cultured Muscle Strength Myogenesis Dynamin 2 Dystrophine Activin Receptors Mitochondrial fission Duchenne muscular dystrophy DMD Calcium Invivo Dystrophie Musculaire de Becker BMD Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS LncARN Génomique Dystrophie musculaire de Becker Gene modifiers Allele‐specific silencing therapy Knockout Muscle Biology Becker muscular dystrophy BMD Duchenne DMD dystrophy Inbred mdx Male Multiresolution modeling Molecular Sequence Data Multi resolution modeling NAD+ Clinical trials MiARN Cardiomyopathy Muscle development Becker BMD muscular dystrophy Dystrophin central domain Molecular docking Cell Line DHPR α1S Energy Metabolism/drug effects Dystrophin-EGFP DMD CaV subunits Humans Multi exon skipping Liver Homeostasis Long noncoding RNA Animals Epigenetics LncRNA Inbred C57BL CaVβs Mice Cardiomyopathie Becker muscular dystrophy Immunoglobulin Fc Fragments/pharmacology Diseases Hear Calcium Channels Skeletal muscle CTNNB1 Mdx mouse Gene expression